Drug:
Reaction: OVERDOSE
20250101 - 20251231
No. 4701 - 4800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 4701 | 24854461 |
US |
5 | 2 |
Overdose, |
||||
OXYCODONE AND ACETAMINOPHEN, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, TRAMADOL HYDROCHLORIDE, HYDROCODONE BITARTRATE AND IBUPROFEN, MORPHINE SULFATE, OXYMORPHONE HYDROCHLORIDE, METHADONE, |
||||
| 4702 | 24854462 |
US |
1 | |
Overdose, Dependence, |
||||
OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 4703 | 24854694 |
US |
2 | |
Gastroenteritis, Cough, Overdose, |
||||
UMECLIDINIUM, |
||||
| 4704 | 24855377 |
US |
1 | |
Dependence, Overdose, |
||||
BUPRENORPHINE HYDROCHLORIDE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN AND CODEINE, FENTANYL, |
||||
| 4705 | 24855502 |
US |
||
Overdose, |
||||
FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE CHEWABLE TABLET, FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE, |
||||
| 4706 | 24855518 |
FR |
82 | 2 |
Renal failure, Hyperkalaemia, Overdose, Lactic acidosis, |
||||
KETOPROFEN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 4707 | 24855747 |
GB |
46 | 2 |
Acute psychosis, Overdose, |
||||
BACLOFEN, |
||||
| 4708 | 24855827 |
CH |
1 | |
Tuberculosis, Paranoia, Nervousness, Anxiety, Overdose, Therapeutic product effect decreased, Product packaging quantity issue, Product physical issue, Product appearance confusion, |
||||
DEXMETHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE, ALPRAZOLAM, |
||||
| 4709 | 24856000 |
US |
1 | |
Dependence, Overdose, Ill-defined disorder, |
||||
OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE, OXYCODONE HYDROCHLORIDE, |
||||
| 4710 | 24856007 |
US |
1 | |
Dependence, Overdose, |
||||
HYDROCODONE BITARTRATE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, |
||||
| 4711 | 24856009 |
US |
4 | 2 |
Overdose, Dependence, |
||||
OXYCODONE AND ACETAMINOPHEN, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, |
||||
| 4712 | 24856099 |
IT |
78 | 1 |
Presyncope, Sopor, Drug interaction, Overdose, |
||||
RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, AMITRIPTYLINE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, PREGABALIN, |
||||
| 4713 | 24856357 |
US |
58 | 1 |
Overdose, CHANTER syndrome, |
||||
FENTANYL CITRATE, |
||||
| 4714 | 24856442 |
US |
||
Overdose, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 4715 | 24856565 |
GB |
58 | 1 |
Intestinal resection, Intestinal stenosis, Chest pain, Atrioventricular block second degree, Drug ineffective, Gastrointestinal pain, Gastrointestinal scarring, Flank pain, Overdose, Injection site swelling, |
||||
RISANKIZUMAB-RZAA, AMLODIPINE, |
||||
| 4716 | 24856964 |
JP |
||
Product quality issue, Overdose, |
||||
ROTIGOTINE, |
||||
| 4717 | 24857021 |
US |
21 | 1 |
Device defective, No adverse event, Overdose, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 4718 | 24857105 |
BR |
36 | 2 |
Drug abuse, Drug dependence, Toxicity to various agents, Drug withdrawal syndrome, Drug tolerance, Insomnia, Social problem, Overdose, Somnambulism, Depressive symptom, Dissociative disorder, Exposure during pregnancy, Thinking abnormal, |
||||
ZOLPIDEM TARTRATE, |
||||
| 4719 | 24857106 |
BR |
25 | 2 |
Drug abuse, Drug dependence, Toxicity to various agents, Somnolence, Dissociative disorder, Fall, Amnesia, Disturbance in attention, Drug withdrawal syndrome, Drug tolerance, Insomnia, Social problem, Overdose, Thermal burn, |
||||
ZOLPIDEM TARTRATE, |
||||
| 4720 | 24857107 |
BR |
45 | 2 |
Drug abuse, Drug dependence, Toxicity to various agents, Drug withdrawal syndrome, Insomnia, Social problem, Overdose, Amnesia, Disturbance in attention, Intentional product use issue, Somnolence, Exposure during pregnancy, Stillbirth, Syncope, Abnormal behaviour, Dissociative disorder, Fall, Drug tolerance, |
||||
ZOLPIDEM TARTRATE, |
||||
| 4721 | 24857108 |
BR |
28 | 2 |
Drug abuse, Drug dependence, Toxicity to various agents, Fall, Amnesia, Disturbance in attention, Drug withdrawal syndrome, Drug tolerance, Insomnia, Social problem, Overdose, Seizure, Accident, Head injury, Educational problem, Tremor, Hyperhidrosis, Intentional product use issue, |
||||
ZOLPIDEM TARTRATE, |
||||
| 4722 | 24857109 |
BR |
32 | 2 |
Drug abuse, Drug dependence, Toxicity to various agents, Drug withdrawal syndrome, Drug tolerance, Insomnia, Social problem, Overdose, Seizure, Amnesia, Disturbance in attention, |
||||
ZOLPIDEM TARTRATE, |
||||
| 4723 | 24857682 |
FR |
51 | 1 |
Acute kidney injury, Overdose, Product supply issue, Drug clearance decreased, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 4724 | 24847187 |
CN |
16 | 2 |
Acute kidney injury, Shock, Lactic acidosis, Suicide attempt, Hypotension, Overdose, Intentional overdose, |
||||
AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, |
||||
| 4725 | 24847590 |
IT |
82 | 1 |
Hyperkalaemia, Toxicity to various agents, Lactic acidosis, Acute kidney injury, Overdose, |
||||
APIXABAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, DIGOXIN, TELMISARTAN, |
||||
| 4726 | 24847650 |
US |
2 | |
Overdose, |
||||
OLMESARTAN MEDOXOMIL, |
||||
| 4727 | 24847783 |
ES |
46 | 2 |
Decreased appetite, Vomiting, Nausea, Overdose, Inappropriate schedule of product administration, |
||||
SEMAGLUTIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 4728 | 24848084 |
FR |
||
Hyperkalaemia, Lactic acidosis, Renal failure, Overdose, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, KETOPROFEN, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 4729 | 24848799 |
US |
61 | 2 |
Gastrointestinal disorder, Abdominal pain upper, Constipation, Overdose, |
||||
DULAGLUTIDE, SEMAGLUTIDE, |
||||
| 4730 | 24848833 |
US |
2 | |
Overdose, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 4731 | 24848958 |
IT |
81 | 2 |
Intentional overdose, Prescription drug used without a prescription, Overdose, Victim of homicide, Drug diversion, Hypoglycaemia, Asthenia, Malaise, |
||||
LORAZEPAM, TRAZODONE HYDROCHLORIDE, ALPRAZOLAM, |
||||
| 4732 | 24849018 |
US |
2 | |
Incorrect dose administered by device, Drug dose omission by device, Overdose, Wrong technique in product usage process, Device use issue, Device defective, Headache, Device issue, Arthralgia, Tremor, Migraine, Blister, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 4733 | 24849132 |
KR |
||
Epilepsy, Product administered to patient of inappropriate age, Overdose, Tremor, Insomnia, Lethargy, Somnolence, |
||||
ESCITALOPRAM, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, |
||||
| 4734 | 24849298 |
FR |
62 | 2 |
Altered state of consciousness, Asthenia, Cognitive disorder, Salivary hypersecretion, Overdose, |
||||
CLOZAPINE, SERTRALINE HYDROCHLORIDE, IRBESARTAN, IPRATROPIUM BROMIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, BISOPROLOL FUMARATE, |
||||
| 4735 | 24849681 |
US |
74 | 1 |
Toxicity to various agents, Overdose, |
||||
AMLODIPINE BESYLATE, |
||||
| 4736 | 24849915 |
US |
48 | 2 |
Injection site pain, Overdose, |
||||
DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, |
||||
| 4737 | 24850096 |
CA |
44 | 1 |
Completed suicide, Overdose, Renal impairment, Toxicity to various agents, |
||||
HYDROMORPHONE HYDROCHLORIDE, OLANZAPINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 4738 | 24850209 |
US |
1 | |
Device issue, Product administration error, Overdose, Incorrect dose administered, Unevaluable event, Device malfunction, Device delivery system issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 4739 | 24850372 |
IT |
82 | 1 |
Lactic acidosis, Toxicity to various agents, Overdose, Hyperkalaemia, Acute kidney injury, Oliguria, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, DIGOXIN, TELMISARTAN, APIXABAN, |
||||
| 4740 | 24850840 |
CA |
43 | 1 |
Overdose, |
||||
FENTANYL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CARBAMAZEPINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, METHADONE HYDROCHLORIDE, NALOXONE, |
||||
| 4741 | 24850879 |
US |
||
Product dose omission issue, Product use issue, Adverse drug reaction, Nervousness, Off label use, Overdose, Contusion, Electroencephalogram abnormal, Drug interaction, Seizure, Loss of personal independence in daily activities, Fatigue, Asthenia, Somnolence, Malaise, Tremor, |
||||
LEVETIRACETAM, PREGABALIN, PREGABALIN, METHOTREXATE, METHOTREXATE SODIUM, ERGOCALCIFEROL, |
||||
| 4742 | 24851383 |
US |
16 | 2 |
Overdose, Victim of crime, Drug diversion, |
||||
ALPRAZOLAM, OXYCODONE HYDROCHLORIDE, |
||||
| 4743 | 24851400 |
US |
||
Head injury, Fall, Incoherent, Generalised tonic-clonic seizure, Product dose omission issue, Product dose omission issue, Overdose, Product dose omission issue, Extra dose administered, Product dose omission issue, Incorrect dose administered, Dyskinesia, Seizure, Product dose omission issue, COVID-19, Circumstance or information capable of leading to medication error, |
||||
LISDEXAMFETAMINE DIMESYLATE, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 4744 | 24851488 |
US |
2 | |
Overdose, Product prescribing error, |
||||
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, |
||||
| 4745 | 24851931 |
US |
||
Overdose, Slow response to stimuli, Headache, Dizziness, |
||||
BRIVARACETAM, CLONAZEPAM, |
||||
| 4746 | 24851997 |
US |
1 | |
Overdose, Drug diversion, |
||||
ALPRAZOLAM, ZOLPIDEM TARTRATE, FENTANYL, ALPRAZOLAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 4747 | 24852039 |
US |
0 | 2 |
Foetal exposure during pregnancy, Unresponsive to stimuli, Near death experience, Overdose, Dyspnoea, Irritability, High-pitched crying, Drug screen positive, Drug withdrawal syndrome neonatal, |
||||
MORPHINE SULFATE, FENTANYL, FENTANYL, |
||||
| 4748 | 24852042 |
US |
0 | 1 |
Foetal exposure during pregnancy, Near death experience, Overdose, Dyspnoea, Drug screen positive, Drug withdrawal syndrome neonatal, |
||||
MORPHINE SULFATE, FENTANYL, FENTANYL, |
||||
| 4749 | 24852052 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Contraindicated product administered, Decreased appetite, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Exposure during pregnancy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Incorrect product administration duration, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Off label use, Onychomadesis, Onychomycosis, Osteoarthritis, Overdose, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Product use in unapproved indication, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Underdose, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, |
||||
BUPRENORPHINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, CALCIUM CARBONATE, ANTACID, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, MEPOLIZUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 4750 | 24852072 |
CA |
40 | 2 |
C-reactive protein increased, Confusional state, Contraindicated product administered, Drug hypersensitivity, Drug ineffective, Dyspnoea, Ill-defined disorder, Infusion related reaction, Injection site reaction, Nausea, Off label use, Onychomadesis, Onychomycosis, Pain, Pemphigus, Pericarditis, Product use in unapproved indication, Product use issue, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Swelling, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapeutic product effect incomplete, Treatment failure, Type 2 diabetes mellitus, Wound, C-reactive protein abnormal, Intentional product use issue, Overdose, Underdose, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, BUPRENORPHINE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, CALCIUM CARBONATE, ANTACID, CANDESARTAN, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERGOCALCIFEROL, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, DIATRIZOATE MEGLUMINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NEOMYCIN SULFATE, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, POVIDONE-IODINE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RANITIDINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, VITAMIN A, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, THIAMINE HYDROCHLORIDE, |
||||
| 4751 | 24852598 |
JP |
86 | 1 |
Haematuria, Drug interaction, Overdose, |
||||
EDOXABAN TOSYLATE, EDOXABAN TOSYLATE, EDOXABAN TOSYLATE, VERAPAMIL HYDROCHLORIDE, |
||||
| 4752 | 24852786 |
CZ |
48 | 2 |
Myocardial infarction, Supraventricular tachycardia, Overdose, |
||||
BARICITINIB, |
||||
| 4753 | 24852943 |
JP |
1 | |
Poisoning, Overdose, |
||||
ESCITALOPRAM, |
||||
| 4754 | 24842131 |
CA |
40 | 2 |
Psoriatic arthropathy, Lung disorder, Pemphigus, Inflammation, Blepharospasm, Gait inability, Bursitis, Off label use, Coeliac disease, Lip dry, Vomiting, Hypercholesterolaemia, Gastrooesophageal reflux disease, Drug-induced liver injury, Synovitis, Glossodynia, Musculoskeletal pain, Blood cholesterol increased, Drug ineffective, Fall, Dyspnoea, Liver injury, Joint swelling, Anti-cyclic citrullinated peptide antibody positive, Headache, Abdominal discomfort, Alopecia, Product quality issue, Therapeutic product effect decreased, Exposure during pregnancy, Epilepsy, Blister, Drug intolerance, Night sweats, Breast cancer stage III, Onychomadesis, Hypertension, Hepatic enzyme increased, Wound, Stomatitis, Confusional state, Hepatitis, Lower respiratory tract infection, Product use in unapproved indication, Swelling, Finger deformity, Musculoskeletal stiffness, Nausea, Incorrect product administration duration, C-reactive protein abnormal, Fibromyalgia, Nasopharyngitis, Urticaria, Hypoaesthesia, General physical health deterioration, Nail disorder, Injury, Taste disorder, Peripheral venous disease, Fatigue, Drug hypersensitivity, Osteoarthritis, Dyspepsia, Gastrointestinal disorder, Dizziness, Peripheral swelling, Malaise, Insomnia, Muscular weakness, Obesity, Arthropathy, Rash, Rheumatoid arthritis, Pain, Abdominal distension, Condition aggravated, Impaired healing, Muscle injury, Duodenal ulcer perforation, Mobility decreased, Underdose, Ill-defined disorder, Contraindicated product administered, Neck pain, Intentional product use issue, Liver function test increased, Grip strength decreased, Overdose, Folliculitis, Abdominal pain upper, Systemic lupus erythematosus, Maternal exposure during pregnancy, Live birth, Wound infection, Memory impairment, Weight increased, Wheezing, Product label confusion, Injection site reaction, Diarrhoea, Pain in extremity, Sleep disorder, Type 2 diabetes mellitus, Pneumonia, Dry mouth, C-reactive protein increased, Muscle spasms, Arthralgia, Joint range of motion decreased, Facet joint syndrome, Paraesthesia, Rheumatic fever, Hand deformity, Treatment failure, Pericarditis, Back injury, Adverse reaction, Migraine, Hypersensitivity, Asthenia, Infusion related reaction, Decreased appetite, Irritable bowel syndrome, Depression, Helicobacter infection, Onychomycosis, Intentional product use issue, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, BUPRENORPHINE, GOLIMUMAB, GOLIMUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, ATOMOXETINE HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, SECUKINUMAB, SECUKINUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CORTISONE ACETATE, CORTISONE ACETATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, AZATHIOPRINE, ERENUMAB-AOOE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, ETANERCEPT, ETANERCEPT, ETANERCEPT, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, MEPOLIZUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, CELECOXIB, CELECOXIB, CELECOXIB, BOTULINUM TOXIN TYPE A, CANDESARTAN, |
||||
| 4755 | 24842608 |
US |
1 | |
Multiple sclerosis relapse, Confusional state, Overdose, |
||||
DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, BACLOFEN, |
||||
| 4756 | 24842752 |
EU |
20 | 2 |
Hepatic encephalopathy, Acute hepatic failure, Overdose, Abdominal pain, Vomiting, Pyrexia, Choluria, Pallor, Ocular icterus, Abdominal tenderness, Hepatomegaly, Behaviour disorder, Irregular sleep wake rhythm disorder, Somnolence, Respiratory alkalosis, Hepatic cytolysis, Hypoalbuminaemia, Pancytopenia, Coagulopathy, Hyperammonaemia, Hepatitis acute, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 4757 | 24843103 |
FR |
51 | 2 |
Gastric perforation, Hepatic artery aneurysm, Pathogen resistance, Gastrointestinal haemorrhage, Fungal disease carrier, Hepatic cytolysis, Peritonitis, Renal aneurysm, Intentional product use issue, Overdose, Off label use, |
||||
VORICONAZOLE, VORICONAZOLE, VORICONAZOLE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 4758 | 24843692 |
CA |
30 | 1 |
Cardio-respiratory arrest, Drug abuse, Toxicity to various agents, Overdose, |
||||
METHYLPHENIDATE HYDROCHLORIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), CLONAZEPAM, OXAZEPAM, TEMAZEPAM, PREGABALIN, NAPROXEN, NAPROXEN SODIUM, OXYCODONE, |
||||
| 4759 | 24844506 |
CN |
19 | 1 |
Delirium, Somnolence, Overdose, Upper gastrointestinal haemorrhage, Melaena, |
||||
ZOLPIDEM TARTRATE, LORAZEPAM, |
||||
| 4760 | 24844577 |
US |
2 | |
Death, Pollakiuria, Diarrhoea, Headache, Peripheral swelling, Device delivery system issue, Device delivery system issue, Overdose, |
||||
TREPROSTINIL, TREPROSTINIL, RIOCIGUAT, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ATORVASTATIN CALCIUM, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, AZATHIOPRINE, MACITENTAN, FUROSEMIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, MAGNESIUM, GABAPENTIN, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, PROMETHAZINE, AMOXICILLIN AND CLAVULANATE POTASSIUM, OXYGEN, 0XYGEN, ALENDRONATE SODIUM, CETIRIZINE HYDROCHLORIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
| 4761 | 24844602 |
CN |
33 | 2 |
Overdose, Cystoid macular oedema, Retinopathy, |
||||
HYDROXYCHLOROQUINE SULFATE, |
||||
| 4762 | 24844875 |
DE |
46 | 1 |
Serotonin syndrome, Dizziness, Nausea, Hyperhidrosis, Overdose, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 4763 | 24845020 |
FR |
51 | 2 |
Gastric perforation, Peritonitis, Hepatic artery aneurysm, Gastrointestinal haemorrhage, Renal aneurysm, Hepatic cytolysis, Overdose, |
||||
VORICONAZOLE, VORICONAZOLE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 4764 | 24845025 |
US |
59 | 2 |
Off label use, Hepatic enzyme increased, Overdose, |
||||
BARICITINIB, |
||||
| 4765 | 24845581 |
US |
41 | |
Overdose, Product prescribing error, |
||||
BUPRENORPHINE, ALPRAZOLAM, GABAPENTIN, |
||||
| 4766 | 24845651 |
US |
2 | |
Overdose, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 4767 | 24845680 |
DE |
||
Overdose, Wrong technique in product usage process, Product use in unapproved indication, |
||||
LAMOTRIGINE, |
||||
| 4768 | 24846161 |
CH |
71 | 1 |
Paralysis, Insomnia, Pain, Dysarthria, Dyskinesia, Therapeutic product effect incomplete, Aphasia, Overdose, Device defective, Muscle spasticity, |
||||
| 4769 | 24846191 |
32 | 1 | |
Drug use disorder, Dependence, Overdose, Dental operation, Inability to afford medication, |
||||
OXYCODONE, BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, |
||||
| 4770 | 24846425 |
US |
1 | |
Overdose, Drug dependence, |
||||
OXYCODONE HYDROCHLORIDE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, |
||||
| 4771 | 24846680 |
JP |
2 | |
Vomiting, Feeling abnormal, Overdose, Hyperphagia, |
||||
DONEPEZIL HYDROCHLORIDE, |
||||
| 4772 | 24847155 |
GB |
45 | 1 |
CHANTER syndrome, Overdose, |
||||
PREGABALIN, METHADONE, |
||||
| 4773 | 24839060 |
BR |
57 | 1 |
COVID-19, Immune effector cell-associated neurotoxicity syndrome, Feeling cold, Tremor, B precursor type acute leukaemia, Overdose, |
||||
BLINATUMOMAB, BLINATUMOMAB, BLINATUMOMAB, BLINATUMOMAB, ACYCLOVIR, URSODIOL, URSOSIOL, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
| 4774 | 24839836 |
US |
2 | |
Overdose, |
||||
FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, |
||||
| 4775 | 24840181 |
ES |
66 | 2 |
Pruritus allergic, Overdose, |
||||
| 4776 | 24840309 |
DE |
63 | 2 |
Death, Dementia, Overdose, |
||||
| 4777 | 24840611 |
US |
2 | |
Constipation, Loss of consciousness, Blood pressure fluctuation, Psychotic disorder, Delirium, Drug abuse, Serotonin syndrome, Hallucination, auditory, Encephalopathy, Amnesia, Feeling of body temperature change, Tremor, Drug interaction, Drug withdrawal syndrome, Restlessness, Piloerection, Hyperhidrosis, Oxygen saturation decreased, Abdominal pain upper, Overdose, Mydriasis, Insomnia, Rash vesicular, Nystagmus, |
||||
VELPATASVIR AND SOFOSBUVIR, CARIPRAZINE, BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE, OLANZAPINE, OLANZAPINE PAMOATE, NORGESTIMATE AND ETHINYL ESTRADIOL, QUETIAPINE, LEVOTHYROXINE SODIUM, ARIPIPRAZOLE, |
||||
| 4778 | 24841358 |
CN |
78 | 1 |
Somnolence, Oxygen saturation decreased, Overdose, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 4779 | 24841703 |
US |
17 | 1 |
Overdose, Wrong product administered, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 4780 | 24841712 |
US |
14 | |
Overdose, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 4781 | 24844309 |
63 | 2 | |
Overdose, Sedation, Intentional overdose, Loss of consciousness, |
||||
GABAPENTIN, |
||||
| 4782 | 24834088 |
GB |
62 | 1 |
Retrograde ejaculation, Abdominal pain upper, Micturition urgency, Dizziness, Overdose, Drug interaction, Product use issue, |
||||
APIXABAN, TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, LISINOPRIL, LISINOPRIL, ALLOPURINOL, |
||||
| 4783 | 24834288 |
US |
40 | 2 |
Toxicity to various agents, Product administration error, Overdose, |
||||
ACETAMINOPHEN,DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 4784 | 24834337 |
HK |
16 | 2 |
Overdose, Hypotension, Acute kidney injury, Suicide attempt, Lactic acidosis, |
||||
AMLODIPINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 4785 | 24834621 |
US |
22 | 1 |
Pneumonia, Overdose, Arteriosclerosis coronary artery, Hepatic steatosis, Drug interaction, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALPRAZOLAM, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, OXAZEPAM, OXYCODONE HYDROCHLORIDE, TEMAZEPAM, |
||||
| 4786 | 24834692 |
FR |
51 | 2 |
Gastric perforation, Hepatic artery aneurysm, Hepatic cytolysis, Gastrointestinal haemorrhage, Peritonitis, Overdose, Off label use, Renal aneurysm, Fungal disease carrier, Intentional product use issue, Pathogen resistance, |
||||
VORICONAZOLE, VORICONAZOLE, VORICONAZOLE, |
||||
| 4787 | 24834792 |
GB |
1 | |
Schizophrenia, Overdose, Therapy cessation, Differential white blood cell count abnormal, |
||||
CLOZAPINE, |
||||
| 4788 | 24834858 |
HK |
16 | 2 |
Shock, Lactic acidosis, Overdose, |
||||
AMLODIPINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, EPINEPHRINE, ADRENALINUM, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, VASOPRESSIN, |
||||
| 4789 | 24835236 |
US |
||
Condition aggravated, Overdose, Off label use, Product availability issue, Paraesthesia, Hypoaesthesia, Contusion, |
||||
| 4790 | 24835422 |
FR |
82 | 2 |
Lactic acidosis, Hyperkalaemia, Renal failure, Overdose, |
||||
KETOPROFEN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 4791 | 24836012 |
US |
61 | 2 |
Overdose, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 4792 | 24836021 |
DE |
57 | 2 |
Acute respiratory failure, Vasoplegia syndrome, Suicide attempt, Toxicity to various agents, Overdose, Drug level increased, Hypotension, |
||||
AMLODIPINE BESYLATE, |
||||
| 4793 | 24836022 |
DE |
61 | 2 |
Multiple organ dysfunction syndrome, Lactic acidosis, Circulatory collapse, Cardiac arrest, Vasoplegia syndrome, Rhabdomyolysis, Compartment syndrome, Overdose, Toxicity to various agents, Drug level increased, |
||||
AMLODIPINE BESYLATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, |
||||
| 4794 | 24836040 |
HK |
16 | 2 |
Shock, Lactic acidosis, Overdose, Toxicity to various agents, Suicide attempt, Metabolic acidosis, |
||||
AMLODIPINE BESYLATE, |
||||
| 4795 | 24836043 |
US |
47 | 1 |
Distributive shock, Toxicity to various agents, Overdose, |
||||
AMLODIPINE BESYLATE, |
||||
| 4796 | 24836045 |
HK |
16 | 2 |
Coma scale abnormal, Lactic acidosis, Acute kidney injury, Hypotension, Overdose, Toxicity to various agents, Suicide attempt, Metabolic acidosis, |
||||
AMLODIPINE BESYLATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 4797 | 24836206 |
FR |
21 | 2 |
Hypoxic-ischaemic encephalopathy, Hypoglycaemia, Drug abuse, Cardio-respiratory arrest, Hyperlactacidaemia, Acidosis, Overdose, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), ALPRAZOLAM, SERTRALINE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 4798 | 24836371 |
US |
1 | |
Multiple organ dysfunction syndrome, Toxicity to various agents, Overdose, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 4799 | 24836530 |
AU |
39 | 1 |
Local anaesthetic systemic toxicity, Hallucination, Blindness transient, Agitation, Paralysis, Overdose, Incorrect dose administered, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 4800 | 24836639 |
US |
17 | 1 |
Brain oedema, Overdose, Toxicity to various agents, Drug abuse, Drug interaction, Pulmonary oedema, Back pain, Vomiting, Product use issue, |
||||
OXYCODONE, MORPHINE, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, CAFFEINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30
